PT  - JOURNAL ARTICLE
AU  - Daniel Podlesny
AU  - W. Florian Fricke
TI  - Microbial Strain Engraftment, Persistence and Replacement after Fecal Microbiota Transplantation
AID  - 10.1101/2020.09.29.20203638
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.29.20203638
4099  - http://medrxiv.org/content/early/2020/09/29/2020.09.29.20203638.short
4100  - http://medrxiv.org/content/early/2020/09/29/2020.09.29.20203638.full
AB  - Fecal Microbiota Transplantation (FMT) has been clinically validated as a treatment for recurrent Clostridioides difficile infection (rCDI) and associated with the compositional and functional restoration of the patient gut microbiota. To characterize the underlying microbiota dynamics of patient and donor strain engraftment, persistence and replacement during FMT, we combined new and existing metagenomic sequence data and developed the bioinformatic SameStr program for the species-specific detection of shared subspecies lineages, including non-dominant strains. We show that personal gut strain profiles are identifiable and detect engraftment after successful and failed FMT in rCDI recipients, specifically of those donor strains that are abundant and stable in healthy individuals. We identify microbiota parameters in statistical models to predict donor species and strain engraftment, as well as recipient strain persistence and replacement. Our findings raise concerns over FMT consequences from questionable donors and suggest that personalized FMT strategies are feasible for targeted microbiota modulation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementD.P. and W.F.F. received funding by the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) under SPP 1656 (Project no. 316130265).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB, Sinai Hospital of Baltimore All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll shotgun metagenomic data from the rCDI Study Cohort were deposited and are available from the European Nucleotide Archive under accession PRJEB39023